Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Determining a Viral Load Threshold for Pre-emptive Therapy for Cytomegalovirus Infection in Transplant Patients
NCT00947141Phase 4Completed
- Sponsor
- University College London
- Start
- Feb 2003
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ganciclovir, valganciclovir, foscarnet sodium in cytomegalovirus infection (CMV), sponsored by University College London. Started Feb 2003; status: completed.
02
Drugs
ganciclovirvalganciclovirfoscarnet sodium
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00947141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00947141.